Testing effectiveness (Phase 2)Study completedNCT01622348
What this trial is testing
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Who this might be right for
Actively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis
Idera Pharmaceuticals, Inc. 44